QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 13-3668640 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, par value $0.01 per share | WAT | New York Stock Exchange, Inc. |
Large accelerated filer | Accelerated filer | ☐ | |||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||
Emerging growth company | ☐ |
PART I | FINANCIAL INFORMATION | Page | ||||||||||
Item 1. | ||||||||||||
3 | ||||||||||||
4 | ||||||||||||
5 | ||||||||||||
6 | ||||||||||||
7 | ||||||||||||
8 | ||||||||||||
9 | ||||||||||||
10 | ||||||||||||
Item 2. | 30 | |||||||||||
Item 3. | 42 | |||||||||||
Item 4. | 42 | |||||||||||
PART II | OTHER INFORMATION | |||||||||||
Item 1. | 43 | |||||||||||
Item 1A. | 43 | |||||||||||
Item 2. | 44 | |||||||||||
Item 6. | 45 | |||||||||||
46 |
September 28, 2019 | December 31, 2018 | |||||||
(In thousands, except per share data) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 404,649 | $ | 796,280 | ||||
Investments | — | 938,944 | ||||||
Accounts receivable, net | 504,865 | 568,316 | ||||||
Inventories | 368,790 | 291,569 | ||||||
Other current assets | 65,602 | 68,054 | ||||||
Total current assets | 1,343,906 | 2,663,163 | ||||||
Property, plant and equipment, net | 381,496 | 343,083 | ||||||
Intangible assets, net | 237,610 | 246,902 | ||||||
Goodwill | 353,938 | 355,614 | ||||||
Operating lease assets | 85,112 | — | ||||||
Other assets | 159,203 | 118,664 | ||||||
Total assets | $ | 2,561,265 | $ | 3,727,426 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Notes payable and debt | $ | 100,058 | $ | 178 | ||||
Accounts payable | 64,805 | 68,168 | ||||||
Accrued employee compensation | 33,040 | 64,545 | ||||||
Deferred revenue and customer advances | 197,401 | 164,965 | ||||||
Current operating lease liabilities | 23,936 | — | ||||||
Accrued treasury stock repurchases | 18,016 | 23,005 | ||||||
Accrued income taxes | 49,576 | 22,943 | ||||||
Accrued warranty | 11,477 | 12,300 | ||||||
Other current liabilities | 98,844 | 92,827 | ||||||
Total current liabilities | 597,153 | 448,931 | ||||||
Long-term liabilities: | ||||||||
Long-term debt | 1,255,601 | 1,148,172 | ||||||
Long-term income tax liabilities | 393,863 | 430,866 | ||||||
Long-term operating lease liabilities | 61,372 | — | ||||||
Long-term portion of retirement benefits | 55,386 | 55,853 | ||||||
Other long-term liabilities | 82,390 | 76,346 | ||||||
Total long-term liabilities | 1,848,612 | 1,711,237 | ||||||
Total liabilities | 2,445,765 | 2,160,168 | ||||||
Commitments and contingencies (Notes 6, 7, 8 and 12) | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, par value $0.01 per share, 5,000 shares authorized, 0ne issued at September 28, 2019 and December 31, 2018 | — | — | ||||||
Common stock, par value $0.01 per share, 400,000 shares authorized, 160,869 and 160,472 shares issued, 65,117 and 73,115 shares outstanding at September 28, 2019 and December 31, 2018, respectively | 1,609 | 1,605 | ||||||
Additional paid-in capital | 1,897,771 | 1,834,741 | ||||||
Retained earnings | 6,386,734 | 5,995,205 | ||||||
Treasury stock, at cost, 95,752 and 87,357 shares at September 28, 2019 and December 31, 2018, respectively | (8,051,033 | ) | (6,146,322 | ) | ||||
Accumulated other comprehensive loss | (119,581 | ) | (117,971 | ) | ||||
Total stockholders’ equity | 115,500 | 1,567,258 | ||||||
Total liabilities and stockholders’ equity | $ | 2,561,265 | $ | 3,727,426 | ||||
September 26, 2020 | December 31, 2019 | |||||||
(In thousands, | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 374,934 | $ | 335,715 | ||||
Investments | 22,136 | 1,429 | ||||||
Accounts receivable, net | 494,432 | 587,734 | ||||||
Inventories | 326,946 | 320,551 | ||||||
Other current assets | 73,225 | 67,062 | ||||||
Total current assets | 1,291,673 | 1,312,491 | ||||||
Property, plant and equipment, net | 469,721 | 417,342 | ||||||
Intangible assets, net | 255,168 | 240,203 | ||||||
Goodwill | 431,078 | 356,128 | ||||||
Operating lease assets | 86,757 | 93,358 | ||||||
Other assets | 144,889 | 137,533 | ||||||
Total assets | $ | 2,679,286 | $ | 2,557,055 | ||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Notes payable and debt | $ | 150,000 | $ | 100,366 | ||||
Accounts payable | 60,357 | 49,001 | ||||||
Accrued employee compensation | 46,015 | 43,467 | ||||||
Deferred revenue and customer advances | 211,348 | 176,360 | ||||||
Current operating lease liabilities | 26,745 | 27,125 | ||||||
Accrued income taxes | 60,444 | 45,967 | ||||||
Accrued warranty | 10,261 | 11,964 | ||||||
Other current liabilities | 157,018 | 137,084 | ||||||
Total current liabilities | 722,188 | 591,334 | ||||||
Long-term liabilities: | ||||||||
Long-term debt | 1,421,337 | 1,580,797 | ||||||
Long-term portion of retirement benefits | 65,003 | 59,159 | ||||||
Long-term income tax liabilities | 356,953 | 394,562 | ||||||
Long-term operating lease liabilities | 62,471 | 66,881 | ||||||
Other long-term liabilities | 92,915 | 80,603 | ||||||
Total long-term liabilities | 1,998,679 | 2,182,002 | ||||||
Total liabilities | 2,720,867 | 2,773,336 | ||||||
Commitments and contingencies (Notes 7, 8 and 12) | ||||||||
Stockholders’ deficit: | ||||||||
Preferred stock, par value $0.01 per share, 5,000 shares authorized, NaN issued at September 26, 2020 and December 31, 2019 | — | — | ||||||
Common stock, par value $0.01 per share, 400,000 shares authorized, 161,381 and 161,030 shares issued, 62,024 and 62,587 shares outstanding at September 26, 2020 and December 31, 2019, respectively | 1,614 | 1,610 | ||||||
Additional paid-in capital | 1,982,731 | 1,926,753 | ||||||
Retained earnings | 6,889,678 | 6,587,403 | ||||||
Treasury stock, at cost, 99,357 and 98,443 shares at September 26, 2020 and December 31, 2019, respectively | (8,788,928 | ) | (8,612,576 | ) | ||||
Accumulated other comprehensive loss | (126,676 | ) | (119,471 | ) | ||||
Total stockholders’ deficit | (41,581 | ) | (216,281 | ) | ||||
Total liabilities and stockholders’ deficit | $ | 2,679,286 | $ | 2,557,055 | ||||
Three Months Ended | ||||||||
September 28, 2019 | September 29, 2018 | |||||||
(In thousands, except per share data) | ||||||||
Revenues: | ||||||||
Product sales | $ | 370,573 | $ | 378,522 | ||||
Service sales | 206,705 | 199,499 | ||||||
Total net sales | 577,278 | 578,021 | ||||||
Costs and operating expenses: | ||||||||
Cost of product sales | 149,793 | 155,825 | ||||||
Cost of service sales | 91,262 | 85,314 | ||||||
Selling and administrative expenses | 126,036 | 126,997 | ||||||
Research and development expenses | 34,333 | 35,173 | ||||||
Purchased intangibles amortization | 2,619 | 2,114 | ||||||
Litigation provision | — | 924 | ||||||
Total costs and operating expenses | 404,043 | 406,347 | ||||||
Operating income | 173,235 | 171,674 | ||||||
Other expense | (496 | ) | (811 | ) | ||||
Interest expense | (11,456 | ) | (11,435 | ) | ||||
Interest income | 3,455 | 9,802 | ||||||
Income before income taxes | 164,738 | 169,230 | ||||||
Provision for income taxes | 26,605 | 28,216 | ||||||
Net income | $ | 138,133 | $ | 141,014 | ||||
Net income per basic common share | $ | 2.09 | $ | 1.84 | ||||
Weighted-average number of basic common shares | 66,226 | 76,575 | ||||||
Net income per diluted common share | $ | 2.07 | $ | 1.83 | ||||
Weighted-average number of diluted common shares and equivalents | 66,768 | 77,136 |
Three Months Ended | ||||||||
September 26, 2020 | September 28, 2019 | |||||||
(In thousands, except per share data) | ||||||||
Revenues: | ||||||||
Product sales | $ | 376,239 | $ | 370,573 | ||||
Service sales | 217,545 | 206,705 | ||||||
Total net sales | 593,784 | 577,278 | ||||||
Costs and operating expenses: | ||||||||
Cost of product sales | 166,330 | 149,793 | ||||||
Cost of service sales | 96,012 | 91,262 | ||||||
Selling and administrative expenses | 135,430 | 126,036 | ||||||
Research and development expenses | 34,971 | 34,333 | ||||||
Purchased intangibles amortization | 2,657 | 2,619 | ||||||
Total costs and operating expenses | 435,400 | 404,043 | ||||||
Operating income | 158,384 | 173,235 | ||||||
Other expense | (1,039 | ) | (496 | ) | ||||
Interest expense | (10,915 | ) | (11,456 | ) | ||||
Interest income | 4,007 | 3,455 | ||||||
Income before income taxes | 150,437 | 164,738 | ||||||
Provision for income taxes | 23,668 | 26,605 | ||||||
Net income | $ | 126,769 | $ | 138,133 | ||||
Net income per basic common share | $ | 2.04 | $ | 2.09 | ||||
Weighted-average number of basic common shares | 62,002 | 66,226 | ||||||
Net income per diluted common share | $ | 2.03 | $ | 2.07 | ||||
Weighted-average number of diluted common shares and equivalents | 62,303 | 66,768 |
Nine Months Ended | ||||||||
September 28, 2019 | September 29, 2018 | |||||||
(In thousands, except per share data) | ||||||||
Revenues: | ||||||||
Product sales | $ | 1,078,341 | $ | 1,106,508 | ||||
Service sales | 611,961 | 598,402 | ||||||
Total net sales | 1,690,302 | 1,704,910 | ||||||
Costs and operating expenses: | ||||||||
Cost of product sales | 439,158 | 456,270 | ||||||
Cost of service sales | 272,474 | 249,425 | ||||||
Selling and administrative expenses | 393,583 | 394,049 | ||||||
Research and development expenses | 105,883 | 105,297 | ||||||
Purchased intangibles amortization | 7,164 | 5,375 | ||||||
Litigation settlement | — | (748 | ) | |||||
Total costs and operating expenses | 1,218,262 | 1,209,668 | ||||||
Operating income | 472,040 | 495,242 | ||||||
Other expense | (1,363 | ) | (2,293 | ) | ||||
Interest expense | (34,467 | ) | (36,965 | ) | ||||
Interest income | 17,641 | 28,356 | ||||||
Income before income taxes | 453,851 | 484,340 | ||||||
Provision for income taxes | 62,322 | 75,698 | ||||||
Net income | $ | 391,529 | $ | 408,642 | ||||
Net income per basic common share | $ | 5.68 | $ | 5.26 | ||||
Weighted-average number of basic common shares | 68,952 | 77,741 | ||||||
Net income per diluted common share | $ | 5.63 | $ | 5.21 | ||||
Weighted-average number of diluted common shares and equivalents | 69,533 | 78,395 |
Nine Months Ended | ||||||||
September 26, 2020 | September 28, 2019 | |||||||
(In thousands, except per share data) | ||||||||
Revenues: | ||||||||
Product sales | $ | 965,342 | $ | 1,078,341 | ||||
Service sales | 613,365 | 611,961 | ||||||
Total net sales | 1,578,707 | 1,690,302 | ||||||
Costs and operating expenses: | ||||||||
Cost of product sales | 420,971 | 439,158 | ||||||
Cost of service sales | 265,149 | 272,474 | ||||||
Selling and administrative expenses | 400,614 | 393,583 | ||||||
Research and development expenses | 101,115 | 105,883 | ||||||
Purchased intangibles amortization | 7,900 | 7,164 | ||||||
Litigation provision | 1,180 | — | ||||||
Total costs and operating expenses | 1,196,929 | 1,218,262 | ||||||
Operating income | 381,778 | 472,040 | ||||||
Other expense | (2,149 | ) | (1,363 | ) | ||||
Interest expense | (38,012 | ) | (34,467 | ) | ||||
Interest income | 12,046 | 17,641 | ||||||
Income before income taxes | 353,663 | 453,851 | ||||||
Provision for income taxes | 50,403 | 62,322 | ||||||
Net income | $ | 303,260 | $ | 391,529 | ||||
Net income per basic common share | $ | 4.89 | $ | 5.68 | ||||
Weighted-average number of basic common shares | 62,057 | 68,952 | ||||||
Net income per diluted common share | $ | 4.86 | $ | 5.63 | ||||
Weighted-average number of diluted common shares and equivalents | 62,371 | 69,533 |
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Net income | $ | 138,133 | $ | 141,014 | $ | 391,529 | $ | 408,642 | ||||||||
Other comprehensive (loss) income: | ||||||||||||||||
Foreign currency translation | (4,894 | ) | 5,309 | (4,403 | ) | (17,937 | ) | |||||||||
Unrealized (losses) gains on investments before income taxes | (8 | ) | 1,631 | 3,046 | 108 | |||||||||||
Income tax benefit (expense) | 2 | (382 | ) | (702 | ) | (125 | ) | |||||||||
Unrealized (losses) gains on investments, net of tax | (6 | ) | 1,249 | 2,344 | (17 | ) | ||||||||||
Retirement liability adjustment before reclassifications | 267 | (177 | ) | 165 | 107 | |||||||||||
Amounts reclassified to other income | 88 | 904 | 271 | 2,720 | ||||||||||||
Retirement liability adjustment before income taxes | 355 | 727 | 436 | 2,827 | ||||||||||||
Income tax benefit (expense) | 60 | (177 | ) | 13 | (599 | ) | ||||||||||
Retirement liability adjustment, net of tax | 415 | 550 | 449 | 2,228 | ||||||||||||
Other comprehensive (loss) income | (4,485 | ) | 7,108 | (1,610 | ) | (15,726 | ) | |||||||||
Comprehensive income | $ | 133,648 | $ | 148,122 | $ | 389,919 | $ | 392,916 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Net income | $ | 126,769 | $ | 138,133 | $ | 303,260 | $ | 391,529 | ||||||||
Other comprehensive income (loss): | ||||||||||||||||
Foreign currency translation | 601 | (4,894 | ) | (7,156 | ) | (4,403 | ) | |||||||||
Unrealized (losses) gains on investments before income taxes | — | (8 | ) | — | 3,046 | |||||||||||
Income tax benefit (expense) | — | 2 | — | (702 | ) | |||||||||||
Unrealized (losses) gains on investments, net of tax | — | (6 | ) | — | 2,344 | |||||||||||
Retirement liability adjustment before reclassifications | (654 | ) | 267 | (880 | ) | 165 | ||||||||||
Amounts reclassified to other income | 352 | 88 | 1,028 | 271 | ||||||||||||
Retirement liability adjustment before income taxes | (302 | ) | 355 | 148 | 436 | |||||||||||
Income tax (expense) benefit | (85 | ) | 60 | (197 | ) | 13 | ||||||||||
Retirement liability adjustment, net of tax | (387 | ) | 415 | (49 | ) | 449 | ||||||||||
Other comprehensive income (loss) | 214 | (4,485 | ) | (7,205 | ) | (1,610 | ) | |||||||||
Comprehensive income | $ | 126,983 | $ | 133,648 | $ | 296,055 | $ | 389,919 | ||||||||
Nine Months Ended | ||||||||
September 28, 2019 | September 29, 2018 | |||||||
(In thousands) | ||||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 391,529 | $ | 408,642 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Stock-based compensation | 28,917 | 28,184 | ||||||
Deferred income taxes | 1,817 | 278 | ||||||
Depreciation | 42,168 | 44,710 | ||||||
Amortization of intangibles | 38,151 | 38,101 | ||||||
Change in operating assets and liabilities: | ||||||||
Decrease in accounts receivable | 57,897 | 36,893 | ||||||
Increase in inventories | (83,973 | ) | (47,826 | ) | ||||
Increase in other current assets | (6,259 | ) | (21,091 | ) | ||||
Increase in other assets | (9,302 | ) | (3,251 | ) | ||||
Decrease in accounts payable and other current liabilities | (493 | ) | (93,637 | ) | ||||
Increase in deferred revenue and customer advances | 34,926 | 23,085 | ||||||
Effect of the 2017 Tax Cuts & Jobs Act | (3,229 | ) | 12,450 | |||||
Decrease in other liabilities | (40,957 | ) | (3,641 | ) | ||||
Net cash provided by operating activities | 451,192 | 422,897 | ||||||
Cash flows from investing activities: | ||||||||
Additions to property, plant, equipment and software capitalization | (110,205 | ) | (64,215 | ) | ||||
Asset acquisitions | — | (31,486 | ) | |||||
Investment in unaffiliated companies | (7,250 | ) | (7,615 | ) | ||||
Purchases of investments | (35,523 | ) | (908,147 | ) | ||||
Maturities and sales of investments | 978,419 | 2,269,181 | ||||||
Net cash provided by investing activities | 825,441 | 1,257,718 | ||||||
Cash flows from financing activities: | ||||||||
Proceeds from debt issuances | 600,362 | 10 | ||||||
Payments on debt | (390,482 | ) | (850,000 | ) | ||||
Payments of debt issuance costs | (2,932 | ) | — | |||||
Proceeds from stock plans | 34,311 | 42,377 | ||||||
Purchases of treasury shares | (1,909,700 | ) | (816,649 | ) | ||||
Proceeds from (payments for) derivative contracts | 6,900 | (2,181 | ) | |||||
Net cash used in financing activities | (1,661,541 | ) | (1,626,443 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (6,723 | ) | (7,118 | ) | ||||
(Decrease) increase in cash and cash equivalents | (391,631 | ) | 47,054 | |||||
Cash and cash equivalents at beginning of period | 796,280 | 642,319 | ||||||
Cash and cash equivalents at end of period | $ | 404,649 | $ | 689,373 | ||||
Nine Months Ended | ||||||||
September 26, 2020 | September 28, 2019 | |||||||
Cash flows from operating activities: | (In thousands) | |||||||
Net income | $ | 303,260 | $ | 391,529 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Stock-based compensation | 27,715 | 28,917 | ||||||
Deferred income taxes | 1,089 | 1,817 | ||||||
Depreciation | 49,407 | 42,168 | ||||||
Amortization of intangibles | 41,684 | 38,151 | ||||||
Change in operating assets and liabilities: | ||||||||
Decrease in accounts receivable | 96,955 | 57,897 | ||||||
Increase in inventories | (8,139 | ) | (83,973 | ) | ||||
Increase in other current assets | (16,776 | ) | (6,259 | ) | ||||
Increase in other assets | (2,612 | ) | (9,302 | ) | ||||
Increase (decrease) in accounts payable and other current liabilities | 46,721 | (493 | ) | |||||
Increase in deferred revenue and customer advances | 32,053 | 34,926 | ||||||
Effect of the 2017 Tax Cuts & Jobs Act | — | (3,229 | ) | |||||
Decrease in other liabilities | (48,332 | ) | (40,957 | ) | ||||
Net cash provided by operating activities | 523,025 | 451,192 | ||||||
Cash flows from investing activities: | ||||||||
Additions to property, plant, equipment and software capitalization | (125,340 | ) | (110,205 | ) | ||||
Business acquisitions, net of cash acquired | (76,664 | ) | — | |||||
Investment in unaffiliated companies | (3,850 | ) | (7,250 | ) | ||||
Purchases of investments | (22,458 | ) | (35,523 | ) | ||||
Maturities and sales of investments | 1,751 | 978,419 | ||||||
Net cash (used in) provided by investing activities | (226,561 | ) | 825,441 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from debt issuances | 315,000 | 600,362 | ||||||
Payments on debt | (425,366 | ) | (390,482 | ) | ||||
Payments of debt issuance costs | — | (2,932 | ) | |||||
Proceeds from stock plans | 28,421 | 34,311 | ||||||
Purchases of treasury shares | (196,353 | ) | (1,909,700 | ) | ||||
Proceeds from derivative contracts | 10,330 | 6,900 | ||||||
Net cash used in financing activities | (267,968 | ) | (1,661,541 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | 10,723 | (6,723 | ) | |||||
Increase (decrease) in cash and cash equivalents | 39,219 | (391,631 | ) | |||||
Cash and cash equivalents at beginning of period | 335,715 | 796,280 | ||||||
Cash and cash equivalents at end of period | $ | 374,934 | $ | 404,649 | ||||
Number Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance June 30, 2018 | 160,298 | $ | 1,603 | $ | 1,798,708 | $ | 5,669,039 | $ | (5,361,355 | ) | $ | (132,901 | ) | $ | 1,975,094 | |||||||||||||
Net income | — | — | — | 141,014 | — | — | 141,014 | |||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | 7,108 | 7,108 | |||||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 10 | — | 1,789 | — | — | — | 1,789 | |||||||||||||||||||||
Stock options exercised | 52 | 1 | 5,743 | — | — | — | 5,744 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (263,505 | ) | — | (263,505 | ) | |||||||||||||||||||
Stock-based compensation | 8 | — | 9,188 | — | — | — | 9,188 | |||||||||||||||||||||
Balance September 29, 2018 | 160,368 | $ | 1,604 | $ | 1,815,428 | $ | 5,810,053 | $ | (5,624,860 | ) | $ | (125,793 | ) | $ | 1,876,432 | |||||||||||||
Number Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance June 29, 2019 | 160,841 | $ | 1,608 | $ | 1,883,958 | $ | 6,248,601 | $ | (7,462,826 | ) | $ | (115,096 | ) | $ | 556,245 | |||||||||||||
Net income | — | — | — | 138,133 | — | — | 138,133 | |||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (4,485 | ) | (4,485 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 8 | — | 1,803 | — | — | — | 1,803 | |||||||||||||||||||||
Stock options exercised | 19 | — | 2,378 | — | — | — | 2,378 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (588,207 | ) | — | (588,207 | ) | |||||||||||||||||||
Stock-based compensation | 1 | 1 | 9,632 | — | — | — | 9,633 | |||||||||||||||||||||
Balance September 28, 2019 | 160,869 | $ | 1,609 | $ | 1,897,771 | $ | 6,386,734 | $ | (8,051,033 | ) | $ | (119,581 | ) | $ | 115,500 | |||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Loss | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance June 29, | 160,841 | $ | 1,608 | $ | 1,883,958 | $ | 6,248,601 | $ | (7,462,826 | ) | $ | (115,096 | ) | $ | 556,245 | |||||||||||||
Net income | — | — | — | 138,133 | — | — | 138,133 | |||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (4,485 | ) | (4,485 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 8 | — | 1,803 | — | — | — | 1,803 | |||||||||||||||||||||
Stock options exercised | 19 | — | 2,378 | — | — | — | 2,378 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (588,207 | ) | — | (588,207 | ) | |||||||||||||||||||
Stock-based compensation | 1 | 1 | 9,632 | — | — | — | 9,633 | |||||||||||||||||||||
Balance September 28, 2019 | 160,869 | $ | 1,609 | $ | 1,897,771 | $ | 6,386,734 | $ | (8,051,033 | ) | $ | (119,581 | ) | $ | 115,500 | |||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Deficit | ||||||||||||||||||||||
Balance June 27, | 161,273 | $ | 1,613 | $ | 1,959,498 | $ | 6,762,909 | $ | (8,788,872 | ) | $ | (126,890 | ) | $ | (191,742 | ) | ||||||||||||
Net income | — | — | — | 126,769 | — | — | 126,769 | |||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | 214 | 214 | |||||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 10 | — | 1,641 | — | — | — | 1,641 | |||||||||||||||||||||
Stock options exercised | 97 | 1 | 12,040 | — | — | — | 12,041 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (56 | ) | — | (56 | ) | |||||||||||||||||||
Stock-based compensation | 1 | 9,552 | — | — | — | 9,552 | ||||||||||||||||||||||
Balance September 26, 2020 | 161,381 | $ | 1,614 | $ | 1,982,731 | $ | 6,889,678 | $ | (8,788,928 | ) | $ | (126,676 | ) | $ | (41,581 | ) | ||||||||||||
Number Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance December 31, 2017 | 159,845 | $ | 1,598 | $ | 1,745,088 | $ | 5,405,380 | $ | (4,808,211 | ) | $ | (110,067 | ) | $ | 2,233,788 | |||||||||||||
Adoption of new accounting pronouncement | — | — | — | (3,969 | ) | — | — | (3,969 | ) | |||||||||||||||||||
Net income | — | — | — | 408,642 | — | — | 408,642 | |||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (15,726 | ) | (15,726 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 34 | — | 5,840 | — | — | — | 5,840 | |||||||||||||||||||||
Stock options exercised | 357 | 4 | 36,521 | — | — | — | 36,525 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (816,649 | ) | — | (816,649 | ) | |||||||||||||||||||
Stock-based compensation | 132 | 2 | 27,979 | — | — | — | 27,981 | |||||||||||||||||||||
Balance September 29, 2018 | 160,368 | $ | 1,604 | $ | 1,815,428 | $ | 5,810,053 | $ | (5,624,860 | ) | $ | (125,793 | ) | $ | 1,876,432 | |||||||||||||
Number Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance December 31, 2018 | 160,472 | $ | 1,605 | $ | 1,834,741 | $ | 5,995,205 | $ | (6,146,322 | ) | $ | (117,971 | ) | $ | 1,567,258 | |||||||||||||
Net income | — | — | — | 391,529 | — | — | 391,529 | |||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (1,610 | ) | (1,610 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 33 | — | 5,971 | — | — | — | 5,971 | |||||||||||||||||||||
Stock options exercised | 256 | 3 | 28,475 | — | — | — | 28,478 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (1,904,711 | ) | — | (1,904,711 | ) | |||||||||||||||||||
Stock-based compensation | 108 | 1 | 28,584 | — | — | — | 28,585 | |||||||||||||||||||||
Balance September 28, 2019 | 160,869 | $ | 1,609 | $ | 1,897,771 | $ | 6,386,734 | $ | (8,051,033 | ) | $ | (119,581 | ) | $ | 115,500 | |||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Loss | Total Stockholders’ Equity | ||||||||||||||||||||||
Balance December 31, 2018 | 160,472 | $ | 1,605 | $ | 1,834,741 | $ | 5,995,205 | $ | (6,146,322 | ) | $ | (117,971 | ) | $ | 1,567,258 | |||||||||||||
Net income | — | — | — | 391,529 | — | — | 391,529 | |||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (1,610 | ) | (1,610 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 33 | — | 5,971 | — | — | — | 5,971 | |||||||||||||||||||||
Stock options exercised | 256 | 3 | 28,475 | — | — | — | 28,478 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (1,904,711 | ) | — | (1,904,711 | ) | |||||||||||||||||||
Stock-based compensation | 108 | 1 | 28,584 | — | — | — | 28,585 | |||||||||||||||||||||
Balance September 28, 2019 | 160,869 | $ | 1,609 | $ | 1,897,771 | $ | 6,386,734 | $ | (8,051,033 | ) | $ | (119,581 | ) | $ | 115,500 | |||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Loss | Total Stockholders’ Deficit | ||||||||||||||||||||||
Balance December 31, 2019 | 161,030 | $ | 1,610 | $ | 1,926,753 | $ | 6,587,403 | $ | (8,612,576 | ) | $ | (119,471 | ) | $ | (216,281 | ) | ||||||||||||
Net income | — | — | — | 303,260 | — | — | 303,260 | |||||||||||||||||||||
Adoption of new accounting pronouncement | — | — | — | (985 | ) | — | — | (985 | ) | |||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (7,205 | ) | (7,205 | ) | |||||||||||||||||||
Issuance of common stock for employees: | ||||||||||||||||||||||||||||
Employee Stock Purchase Plan | 31 | 5,593 | — | — | — | 5,593 | ||||||||||||||||||||||
Stock options exercised | 184 | 2 | 22,944 | — | — | — | 22,946 | |||||||||||||||||||||
Treasury stock | — | — | — | — | (176,352 | ) | — | (176,352 | ) | |||||||||||||||||||
Stock-based compensation | 136 | 2 | 27,441 | — | — | — | 27,443 | |||||||||||||||||||||
Balance September 26, 2020 | 161,381 | $ | 1,614 | $ | 1,982,731 | $ | 6,889,678 | $ | (8,788,928 | ) | $ | (126,676 | ) | $ | (41,581 | ) | ||||||||||||
Balance at Beginning of Period | Additions | Deduction | Balance at End of Period | |||||||||||||
Allowance for Doubtful Accounts | ||||||||||||||||
September 28, 2019 | $ | 7,663 | $ | 6,014 | $ | (5,461 | ) | $ | 8,216 | |||||||
September 29, 2018 | $ | 6,109 | $ | 2,752 | $ | (2,175 | ) | $ | 6,686 |
Balance at Beginning of Period | Impact of CECL Adoption | Additions | Deduction | Balance at End of Period | ||||||||||||||||
Allowance for Doubtful Accounts | ||||||||||||||||||||
September 26, 2020 | $ | 9,560 | $ | 985 | $ | 7,826 | $ | (5,784 | ) | $ | 12,587 | |||||||||
September 28, 2019 | $ | 7,663 | $ | — | $ | 6,014 | $ | (5,461 | ) | $ | 8,216 |
Total at September 28, 2019 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Assets: | ||||||||||||||||
Time deposits | 213 | — | 213 | — | ||||||||||||
Waters 401(k) Restoration Plan assets | 32,796 | 32,796 | — | — | ||||||||||||
Foreign currency exchange contracts | 66 | — | 66 | — | ||||||||||||
Interest rate cross-currency swap agreements | 16,945 | — | 16,945 | — | ||||||||||||
Total | $ | 50,020 | $ | 32,796 | $ | 17,224 | $ | — | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration | $ | 2,822 | $ | — | $ | — | $ | 2,822 | ||||||||
Foreign currency exchange contracts | 826 | — | 826 | — | ||||||||||||
Total | $ | 3,648 | $ | — | $ | 826 | $ | 2,822 | ||||||||
Total at September 26, 2020 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Assets: | ||||||||||||||||
Time deposits | $ | 22,136 | $ | — | $ | 22,136 | $ | — | ||||||||
Waters 401(k) Restoration Plan assets | 34,466 | 34,466 | — | — | ||||||||||||
Foreign currency exchange contracts | 832 | — | 832 | — | ||||||||||||
Total | $ | 57,434 | $ | 34,466 | $ | 22,968 | $ | — | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration | $ | 2,903 | $ | — | $ | — | $ | 2,903 | ||||||||
Foreign currency exchange contracts | 390 | — | 390 | — | ||||||||||||
Interest rate cross-currency swap agreements | 15,190 | — | 15,190 | — | ||||||||||||
Total | $ | 18,483 | $ | — | $ | 15,580 | $ | 2,903 | ||||||||
Total at December 31, 2018 | Quoted Prices in Active Markets for Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Assets: | ||||||||||||||||
U.S. Treasury securities | $ | 164,315 | $ | — | $ | 164,315 | $ | — | ||||||||
Foreign government securities | 3,463 | — | 3,463 | — | ||||||||||||
Corporate debt securities | 723,059 | — | 723,059 | — | ||||||||||||
Time deposits | 108,638 | — | 108,638 | — | ||||||||||||
Waters 401(k) Restoration Plan assets | 33,104 | 33,104 | — | — | ||||||||||||
Foreign currency exchange contracts | 503 | — | 503 | — | ||||||||||||
Interest rate cross-currency swap agreements | 1,093 | 1,093 | ||||||||||||||
Total | $ | 1,034,175 | $ | 33,104 | $ | 1,001,071 | $ | — | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration | $ | 2,476 | $ | — | $ | — | $ | 2,476 | ||||||||
Foreign currency exchange contracts | 224 | — | 224 | — | ||||||||||||
Total | $ | 2,700 | $ | — | $ | 224 | $ | 2,476 | ||||||||
Total at December 31, 2019 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Assets: | ||||||||||||||||
Time deposits | $ | 1,642 | $ | — | $ | 1,642 | $ | — | ||||||||
Waters 401(k) Restoration Plan assets | 30,158 | 30,158 | — | — | ||||||||||||
Foreign currency exchange contracts | 16 | — | 16 | — | ||||||||||||
Interest rate cross-currency swap agreements | 4,485 | 4,485 | ||||||||||||||
Total | $ | 36,301 | $ | 30,158 | $ | 6,143 | $ | — | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration | $ | 2,557 | $ | — | $ | — | $ | 2,557 | ||||||||
Foreign currency exchange contracts | 1,028 | — | 1,028 | — | ||||||||||||
Total | $ | 3,585 | $ | — | $ | 1,028 | $ | 2,557 | ||||||||
September 28, 2019 | December 31, 2018 | |||||||||||||||
Notional Value | Fair Value | Notional Value | Fair Value | |||||||||||||
Foreign currency exchange contracts: | ||||||||||||||||
Other current assets | $ | 24,000 | $ | 66 | $ | 112,212 | $ | 503 | ||||||||
Other current liabilities | $ | 121,580 | $ | 826 | $ | 40,175 | $ | 224 | ||||||||
Interest rate cross-currency swap agreements: | ||||||||||||||||
Other assets | $ | 410,000 | $ | 16,945 | $ | 300,000 | $ | 1,093 | ||||||||
Accumulated other comprehensive income | $ | 16,945 | $ | 1,093 |
September 26, 2020 | December 31, 2019 | |||||||||||||||
Notional Value | Fair Value | Notional Value | Fair Value | |||||||||||||
Foreign currency exchange contracts: | ||||||||||||||||
Other current assets | $ | 57,380 | $ | 832 | $ | 119,576 | $ | 16 | ||||||||
Other current liabilities | $ | 65,536 | $ | 390 | $ | 29,495 | $ | 1,028 | ||||||||
Interest rate cross-currency swap agreements: | ||||||||||||||||
Other (liabilities) assets | $ | 560,000 | $ | (15,190 | ) | $ | 560,000 | $ | 4,485 | |||||||
Accumulated other comprehensive loss (income) | $ | 15,190 | $ | (4,485 | ) |
Financial | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Statement Classification | September 28, 2019 | | | September 29, 2018 | | September 28, 2019 | September 29, 2018 | |||||||||||||
Foreign currency exchange contracts: | ||||||||||||||||||||
Realized losses on closed contracts | Cost of sales | | $ | (3,340 | ) | $ | (23 | ) | $ | (5,858 | ) | $ | (2,158 | ) | ||||||
Unrealized losses on open contracts | Cost of sales | (633 | ) | (5 | ) | (1,040 | ) | (1,092 | ) | |||||||||||
Cumulative net pre-tax losses | Cost of sales | $ | (3,973 | ) | $ | (28 | ) | $ | (6,898 | ) | $ | (3,250 | ) | |||||||
Interest rate cross-currency swap agreements: | ||||||||||||||||||||
Interest earned | Interest income | $ | 2,698 | $ | 927 | $ | 7,848 | $ | 927 | |||||||||||
Unrealized gains on open contracts | Stockholders’ equity | $ | 15,847 | $ | 767 | $ | 15,852 | $ | 767 |
Financial Statement Classification | Three Months Ended | Nine Months Ended | ||||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||||
Foreign currency exchange contracts: | ||||||||||||||||||
Realized gains (losses) on closed contracts | Cost of sales | $ | 1,113 | $ | (3,340 | ) | $ | (45 | ) | $ | (5,858 | ) | ||||||
Unrealized gains (losses) on open contracts | Cost of sales | 808 | (633 | ) | 1,455 | (1,040 | ) | |||||||||||
Cumulative net pre-tax gains (losses) | Cost of sales | $ | 1,921 | $ | (3,973 | ) | $ | 1,410 | $ | (6,898 | ) | |||||||
Interest rate cross-currency swap agreements: | ||||||||||||||||||
Interest earned | Interest income | $ | 3,777 | $ | 2,698 | $ | 11,275 | $ | 7,848 | |||||||||
Unrealized gains on open contracts | Stockholders’ deficit | $ | 19,582 | $ | 15,847 | $ | 19,675 | $ | 15,852 |
Balance at Beginning of Period | Accruals for Warranties | Settlements Made | Balance at End of Period | |||||||||||||
Accrued warranty liability: | ||||||||||||||||
September 28, 2019 | $ | 12,300 | $ | 5,271 | $ | (6,094 | ) | $ | 11,477 | |||||||
September 29, 2018 | $ | 13,026 | $ | 6,068 | $ | (6,901 | ) | $ | 12,193 |
Balance at Beginning of Period | Accruals for Warranties | Settlements Made | Balance at End of Period | |||||||||||||
Accrued warranty liability: | ||||||||||||||||
September 26, 2020 | $ | 11,964 | $ | 5,442 | $ | (7,145 | ) | $ | 10,261 | |||||||
September 28, 2019 | $ | 12,300 | $ | 5,271 | $ | (6,094 | ) | $ | 11,477 |
September 28, 2019 | September 29, 2018 | |||||||
Balance at the beginning of the period | $ | 204,257 | $ | 192,590 | ||||
Recognition of revenue included in balance at beginning of the period | (174,929 | ) | (147,310 | ) | ||||
Revenue deferred during the period, net of revenue recognized | 206,093 | 179,571 | ||||||
Balance at the end of the period | $ | 235,421 | $ | 224,851 | ||||
September 26, 2020 | September 28, 2019 | |||||||
Balance at the beginning of the period | $ | 213,695 | $ | 204,257 | ||||
Recognition of revenue included in balance at beginning of the period | (177,667 | ) | (174,929 | ) | ||||
Revenue deferred during the period, net of revenue recognized | 213,895 | 206,093 | ||||||
Balance at the end of the period | $ | 249,923 | $ | 235,421 | ||||
September 28, 2019 | ||||
Deferred revenue and customer advances expected to be recognized in: | ||||
One year or less | $ | 197,401 | ||
13-24 months | 21,962 | |||
25 months and beyond | 16,058 | |||
Total | $ | 235,421 | ||
September 26, 2020 | ||||
Deferred revenue and customer advances expected to be recognized in: | ||||
One year or less | $ | 211,348 | ||
13-24 months | 22,452 | |||
25 months and beyond | 16,123 | |||
Total | $ | 249,923 | ||
September 28, 2019 | ||||||||||||||||
Amortized Cost | Unrealized Gain | Unrealized Loss | Fair Value | |||||||||||||
Time deposits | 213 | — | — | 213 | ||||||||||||
Total | $ | 213 | $ | — | $ | — | $ | 213 | ||||||||
Amounts included in: | ||||||||||||||||
Cash equivalents | $ | 213 | $ | — | $ | — | $ | 213 | ||||||||
Total | $ | 213 | $ | — | $ | — | $ | 213 | ||||||||
December 31, 2018 | ||||||||||||||||
Amortized | Unrealized | Unrealized | Fair | |||||||||||||
Cost | Gain | Loss | Value | |||||||||||||
U.S. Treasury securities | $ | 164,619 | $ | 16 | $ | (320 | ) | $ | 164,315 | |||||||
Foreign government securities | 3,486 | 1 | (24 | ) | 3,463 | |||||||||||
Corporate debt securities | 725,778 | 41 | (2,760 | ) | 723,059 | |||||||||||
Time deposits | 108,638 | — | — | 108,638 | ||||||||||||
Total | $ | 1,002,521 | $ | 58 | $ | (3,104 | ) | $ | 999,475 | |||||||
Amounts included in: | ||||||||||||||||
Cash equivalents | $ | 60,532 | $ | — | $ | (1 | ) | $ | 60,531 | |||||||
Investments | 941,989 | 58 | (3,103 | ) | 938,944 | |||||||||||
Total | $ | 1,002,521 | $ | 58 | $ | (3,104 | ) | $ | 999,475 | |||||||
September 26, 2020 | ||||||||||||||||
Amortized Cost | Unrealized Gain | Unrealized Loss | Fair Value | |||||||||||||
Time deposits | 22,136 | — | — | 22,136 | ||||||||||||
Total | $ | 22,136 | $ | — | $ | — | $ | 22,136 | ||||||||
Amounts included in: | ||||||||||||||||
Investments | 22,136 | — | — | 22,136 | ||||||||||||
Total | $ | 22,136 | $ | — | $ | — | $ | 22,136 | ||||||||
December 31, 2019 | ||||||||||||||||
Amortized Cost | Unrealized Gain | Unrealized Loss | Fair Value | |||||||||||||
Time deposits | 1,642 | — | — | 1,642 | ||||||||||||
Total | $ | 1,642 | $ | — | $ | — | $ | 1,642 | ||||||||
Amounts included in: | ||||||||||||||||
Cash equivalents | $ | 213 | $ | — | $ | — | $ | 213 | ||||||||
Investments | 1,429 | — | — | 1,429 | ||||||||||||
Total | $ | 1,642 | $ | — | $ | — | $ | 1,642 | ||||||||
September 28, 2019 | December 31, 2018 | |||||||
Due in one year or less | $ | 213 | $ | 797,649 | ||||
Due after one year through three years | — | 201,826 | ||||||
Total | $ | 213 | $ | 999,475 | ||||
September 26, 2020 | December 31, 2019 | |||||||
Due in one year or less | $ | 22,136 | $ | 1,642 | ||||
Total | $ | 22,136 | $ | 1,642 | ||||
September 28, 2019 | December 31, 2018 | |||||||
Raw materials | $ | 126,326 | $ | 111,641 | ||||
Work in progress | 20,705 | 15,552 | ||||||
Finished goods | 221,759 | 164,376 | ||||||
Total inventories | $ | 368,790 | $ | 291,569 | ||||
September 26, 2020 | December 31, 2019 | |||||||
Raw materials | $ | 134,527 | $ | 126,850 | ||||
Work in progress | 20,183 | 15,457 | ||||||
Finished goods | 172,236 | 178,244 | ||||||
Total inventories | $ | 326,946 | $ | 320,551 | ||||
Cash | $ | 713 | ||
Accounts receivable and current other assets | 806 | |||
Inventory | 669 | |||
Prepaid and other assets | 611 | |||
Property, plant and equipment, net | 757 | |||
Operating lease assets | 847 | |||
Intangible assets | 6,960 | |||
Goodwill | 71,632 | |||
Total assets acquired | 82,995 | |||
Accrued expenses and other liabilities | 2,093 | |||
Total consideration | 80,902 | |||
Fair value of minority investment | 3,525 | |||
Cash consideration paid | $ | 77,377 | ||
September 28, 2019 | December 31, 2018 | |||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Weighted- Average Amortization Period | Gross Carrying Amount | Accumulated Amortization | Weighted- Average Amortization Period | |||||||||||||||||||
Capitalized software | $ | 464,983 | $ | 320,309 | 5 years | $ | 454,307 | $ | 307,634 | 5 years | ||||||||||||||
Purchased intangibles | 199,441 | 149,017 | 11 years | 201,566 | 144,184 | 11 years | ||||||||||||||||||
Trademarks and IPR&D | 13,581 | — | — | 13,677 | — | — | ||||||||||||||||||
Licenses | 5,455 | 5,046 | 6 years | 5,568 | 4,875 | 6 years | ||||||||||||||||||
Patents and other intangibles | 80,765 | 52,243 | 8 years | 77,753 | 49,276 | 8 years | ||||||||||||||||||
Total | $ | 764,225 | $ | 526,615 | 7 years | $ | 752,871 | $ | 505,969 | 7 years | ||||||||||||||
September 26, 2020 | December 31, 2019 | |||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Weighted- Average Amortization Period | Gross Carrying Amount | Accumulated Amortization | Weighted- Average Amortization Period | |||||||||||||||||||
Capitalized software | $ | 542,127 | $ | 378,999 | 5 years | $ | 481,986 | $ | 333,255 | 5 years | ||||||||||||||
Purchased intangibles | 209,877 | 159,747 | 11 years | 200,523 | 151,722 | 11 years | ||||||||||||||||||
Trademarks and IPR&D | 13,702 | — | — | 13,782 | — | — | ||||||||||||||||||
Licenses | 5,600 | 5,345 | 6 years | 5,669 | 5,298 | 6 years | ||||||||||||||||||
Patents and other intangibles | 86,972 | 59,019 | 8 years | 83,035 | 54,517 | 8 years | ||||||||||||||||||
Total | $ | 858,278 | $ | 603,110 | 7 years | $ | 784,995 | $ | 544,792 | 7 years | ||||||||||||||
Face Value | ||||||||||||||||
Senior Unsecured Notes | Term | Interest Rate | (in millions) | Maturity Date | ||||||||||||
Series L | 7 years | 3.31 | % | $ | 200 | September 2026 | ||||||||||
Series M | 10 years | 3.53 | % | $ | 300 | September 2029 |
September 28, | December 31, | |||||||
Foreign subsidiary lines of credit | $ | 58 | $ | 178 | ||||
Senior unsecured notes - Series B - 5.00%, due February 2020 | 100,000 | — | ||||||
Total notes payable and debt, current | 100,058 | 178 | ||||||
Senior unsecured notes - Series B - 5.00%, due February 2020 | — | 100,000 | ||||||
Senior unsecured notes - Series E - 3.97%, due March 2021 | 50,000 | 50,000 | ||||||
Senior unsecured notes - Series F - 3.40%, due June 2021 | 100,000 | 100,000 | ||||||
Senior unsecured notes - Series G - 3.92%, due June 2024 | 50,000 | 50,000 | ||||||
Senior unsecured notes - Series H - floating rate*, due June 2024 | 50,000 | 50,000 | ||||||
Senior unsecured notes - Series I - 3.13%, due May 2023 | 50,000 | 50,000 | ||||||
Senior unsecured notes - Series K - 3.44%, due May 2026 | 160,000 | 160,000 | ||||||
Senior unsecured notes - Series L - 3.31%, due September 2026 | 200,000 | — | ||||||
Senior unsecured notes - Series M - 3.53%, due September 2029 | 300,000 | — | ||||||
Credit agreement | 300,000 | 590,000 | ||||||
Unamortized debt issuance costs | (4,399 | ) | (1,828 | ) | ||||
Total long-term debt | 1,255,601 | 1,148,172 | ||||||
Total debt | $ | 1,355,659 | $ | 1,148,350 | ||||
September 26, 2020 | December 31, 2019 | |||||||
Foreign subsidiary lines of credit | $ | — | $ | 366 | ||||
Senior unsecured notes – Series B – 5.00%, due February 2020 | — | 100,000 | ||||||
Senior unsecured notes – Series E – 3.97%, due March 2021 | 50,000 | — | ||||||
Senior unsecured notes – Series F – 3.40%, due June 2021 | 100,000 | — | ||||||
Total notes payable and debt, current | 150,000 | 100,366 | ||||||
Senior unsecured notes – Series E – 3.97%, due March 2021 | — | 50,000 | ||||||
Senior unsecured notes – Series F – 3.40%, due June 2021 | — | 100,000 | ||||||
Senior unsecured notes – Series G – 3.92%, due June 2024 | 50,000 | 50,000 | ||||||
Senior unsecured notes – Series H – floating rate*, due June 2024 | 50,000 | 50,000 | ||||||
Senior unsecured notes – Series I – 3.13%, due May 2023 | 50,000 | 50,000 | ||||||
Senior unsecured notes – Series K – 3.44%, due May 2026 | 160,000 | 160,000 | ||||||
Senior unsecured notes – Series L – 3.31%, due September 2026 | 200,000 | 200,000 | ||||||
Senior unsecured notes – Series M – 3.53%, due September 2029 | 300,000 | 300,000 | ||||||
Credit agreement | 615,000 | 625,000 | ||||||
Unamortized debt issuance costs | (3,663 | ) | (4,203 | ) | ||||
Total long-term debt | 1,421,337 | 1,580,797 | ||||||
Total debt | $ | 1,571,337 | $ | 1,681,163 | ||||
* | Series H senior unsecured notes bear interest at a 3-month LIBOR for that floating rate interest period plus 1.25%. |
September 28, 2019 | September 29, 2018 | |||||||
Balance at the beginning of the period | $ | 26,108 | $ | 5,843 | ||||
Net reductions for lapse of statutes taken during the period | (173 | ) | (189 | ) | ||||
Net additions for tax positions taken during the | — | 18,608 | ||||||
Net additions for tax positions taken during the | 1,314 | 678 | ||||||
Balance at the end of the period | $ | 27,249 | $ | 24,940 |
September 26, 2020 | September 28, 2019 | |||||||
Balance at the beginning of the period | $ | 27,790 | $ | 26,108 | ||||
Net reductions for lapse of statutes taken during the period | (427 | ) | (173 | ) | ||||
Net additions for tax positions taken during the current period | 907 | 1,314 | ||||||
Balance at the end of the period | $ | 28,270 | $ | 27,249 | ||||
2019 | $ | 28,417 | ||
2020 | 23,424 | |||
2021 | 16,032 | |||
2022 | 11,816 | |||
2023 and thereafter | 23,269 | |||
Total future minimum lease payments | $ | 102,958 | ||
Financial Statement Classification | September 28, 2019 | |||||
Assets: | ||||||
Property operating lease assets | Operating lease assets | $ | 57,028 | |||
Automobile operating lease assets | Operating lease assets | 26,122 | ||||
Equipment operating lease assets | Operating lease assets | 1,962 | ||||
Total lease assets | $ | 85,112 | ||||
Liabilities: | ||||||
Current operating lease liabilities | Current operating lease liabilities | $ | 23,936 | |||
Long-term operating lease liabilities | Long-term operating lease liabilities | 61,372 | ||||
Total lease liabilities | $ | 85,308 | ||||
2019 (remaining 3 months) | $ | 6,600 | ||
2020 | 22,727 | |||
2021 | 15,418 | |||
2022 | 8,538 | |||
2023 | 5,931 | |||
2024 and thereafter | 38,482 | |||
Total future minimum lease payments | 97,696 | |||
Less: amount of lease payments representing interest | (12,388 | ) | ||
Present value of future minimum lease payments | 85,308 | |||
Less: current operating lease liabilities | (23,936 | ) | ||
Long-term operating lease liabilities | $ | 61,372 | ||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
Cost of sales | $ | 531 | $ | 488 | $ | 1,673 | $ | 1,696 | ||||||||
Selling and administrative expenses | 7,766 | 6,731 | 23,293 | 22,855 | ||||||||||||
Research and development expenses | 1,365 | 1,994 | 3,951 | 3,633 | ||||||||||||
Total stock-based compensation | $ | 9,662 | $ | 9,213 | $ | 28,917 | $ | 28,184 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
Cost of sales | $ | 645 | $ | 531 | $ | 1,850 | $ | 1,673 | ||||||||
Selling and administrative expenses | 7,747 | 7,766 | 22,472 | 23,293 | ||||||||||||
Research and development expenses | 1,201 | 1,365 | 3,393 | 3,951 | ||||||||||||
Total stock-based compensation | $ | 9,593 | $ | 9,662 | $ | 27,715 | $ | 28,917 | ||||||||
Nine Months Ended | ||||||||
Options Issued and Significant Assumptions Used to Estimate Option Fair Values | September 26, 2020 | September 28, 2019 | ||||||
Options issued in thousands | 267 | 139 | ||||||
Risk-free interest rate | 1.2 | % | 2.5 | % | ||||
Expected life in years | 6 | 5 | ||||||
Expected volatility | 27.8 | % | 24.3 | % | ||||
Expected dividends | — | — |
Nine Months Ended | ||||||||
Options Issued and Significant Assumptions Used to Estimate Option Fair Values | September 28, 2019 | September 29, 2018 | ||||||
Options issued in thousands | 139 | 147 | ||||||
Risk-free interest rate | 2.5 | % | 2.7 | % | ||||
Expected life in years | 5 | 6 | ||||||
Expected volatility | 24.3 | % | 23.2 | % | ||||
Expected dividends | — | — | ||||||
Nine Months Ended | ||||||||
Weighted-Average Exercise Price and Fair Value of Options on the Date of Grant | September 28, 2019 | September 29, 2018 | ||||||
Exercise price | $ | 231.30 | $ | 205.37 | ||||
Fair value | $ | 61.85 | $ | 57.99 |
Nine Months Ended | ||||||||
Weighted-Average Exercise Price and Fair Value of Options on the Date of Grant | September 26, 2020 | September 28, 2019 | ||||||
Exercise price | $ | 215.12 | $ | 231.30 | ||||
Fair value | $ | 62.93 | $ | 61.85 |
Number of Shares | Weighted-Average Exercise Price per Share | |||||||||||||||||||
Outstanding at December 31, 2018 | 1,790 | $ | 38.09 | to | $ | 208.47 | $ | 142.47 | ||||||||||||
Granted | 139 | $ | 183.41 | to | $ | 238.52 | $ | 231.30 | ||||||||||||
Exercised | (256 | ) | $ | 38.09 | to | $ | 208.47 | $ | 111.11 | |||||||||||
Canceled | (74 | ) | $ | 113.36 | to | $ | 238.52 | $ | 159.17 | |||||||||||
Outstanding at September 28, 2019 | 1,599 | $ | 38.09 | to | $ | 238.52 | $ | 154.44 | ||||||||||||
Number of Shares | Exercise Price per Share | Weighted-Average Exercise Price per Share | ||||||||||||||||||
Outstanding at December 31, 2019 | 1,455 | $ | 61.63 | to | $ | 238.52 | $ | 158.61 | ||||||||||||
Granted | 267 | $ | 188.63 | to | $ | 235.06 | $ | 215.12 | ||||||||||||
Exercised | (184 | ) | $ | 61.63 | to | $ | 208.47 | $ | 124.58 | |||||||||||
Canceled | (150 | ) | $ | 128.93 | to | $ | 238.52 | $ | 176.27 | |||||||||||
Outstanding at September 26, 2020 | 1,388 | $ | 75.94 | to | $ | 238.52 | $ | 172.08 | ||||||||||||
Shares | Weighted-Average Fair Value per Share | |||||||
Unvested at December 31, 2018 | 304 | $ | 153.31 | |||||
Granted | 84 | $ | 235.95 | |||||
Vested | (104 | ) | $ | 138.95 | ||||
Forfeited | (23 | ) | $ | 168.73 | ||||
Unvested at September 28, 2019 | 261 | $ | 184.27 | |||||
Shares | Weighted - AverageGrant Date Fair Value per Share | |||||||
Unvested at December 31, 2019 | 260 | $ | 184.70 | |||||
Granted | 119 | $ | 206.99 | |||||
Vested | (87 | ) | $ | 162.12 | ||||
Forfeited | (18 | ) | $ | 187.90 | ||||
Unvested at September 26, 2020 | 274 | $ | 201.34 | |||||
Nine Months Ended | ||||||||
Performance Stock Units Issued and Significant Assumptions Used to Estimate Fair Values | September 28, 2019 | September 29, 2018 | ||||||
Performance stock units issued (in thousands) | 13 | 16 | ||||||
Risk-free interest rate | 2.4 | % | 2.0 | % | ||||
Expected life in years | 2.8 | 2.8 | ||||||
Expected volatility | 23.5 | % | 23.4 | % | ||||
Average volatility of peer companies | 26.2 | % | 25.8 | % | ||||
Correlation coefficient | 34.2 | % | 37.2 | % | ||||
Expected dividends | — | — |
Nine Months Ended | ||||||||
Performance Stock Units Issued and Significant Assumptions Used to Estimate Fair Values | September 26, 2020 | September 28, 2019 | ||||||
Performance stock units issued (in thousands) | 58 | 13 | ||||||
Risk-free interest rate | 1.3 | % | 2.4 | % | ||||
Expected life in years | 2.9 | 2.8 | ||||||
Expected volatility | 25.1 | % | 23.5 | % | ||||
Average volatility of peer companies | 26.1 | % | 26.2 | % | ||||
Correlation coefficient | 36.6 | % | 34.2 | % | ||||
Expected dividends | — | — |
Shares | Weighted-Average Fair Value per Share | |||||||
Unvested at December 31, 2018 | 100 | $ | 212.34 | |||||
Granted | 13 | $ | 372.68 | |||||
Forfeited | (7 | ) | $ | 196.87 | ||||
Unvested at September 28, 2019 | 106 | $ | 233.03 | |||||
Shares | Weighted-Average Fair Value per Share | |||||||
Unvested at December 31, 2019 | 105 | $ | 233.11 | |||||
Granted | 58 | $ | 190.45 | |||||
Vested | (36 | ) | $ | 184.51 | ||||
Forfeited | (25 | ) | $ | 231.35 | ||||
Unvested at September 26, 2020 | 102 | $ | 226.44 | |||||
Three Months Ended September 26, 2020 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 126,769 | 62,002 | $ | 2.04 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 301 | (0.01 | ) | ||||||||
Net income per diluted common share | $ | 126,769 | 62,303 | $ | 2.03 | |||||||
Three Months Ended September 28, 2019 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 138,133 | 66,226 | $ | 2.09 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 542 | (0.02 | ) | ||||||||
Net income per diluted common share | $ | 138,133 | 66,768 | $ | 2.07 | |||||||
Nine Months Ended September 26, 2020 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 303,260 | 62,057 | $ | 4.89 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 314 | (0.03 | ) | ||||||||
Net income per diluted common share | $ | 303,260 | 62,371 | $ | 4.86 | |||||||
Nine Months Ended September 28, 2019 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 391,529 | 68,952 | $ | 5.68 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 581 | (0.05 | ) | ||||||||
Net income per diluted common share | $ | 391,529 | 69,533 | $ | 5.63 | |||||||
Three Months Ended September 29, 2018 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 141,014 | 76,575 | $ | 1.84 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 561 | (0.01 | ) | ||||||||
Net income per diluted common share | $ | 141,014 | 77,136 | $ | 1.83 | |||||||
Nine Months Ended September 28, 2019 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 391,529 | 68,952 | $ | 5.68 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 581 | (0.05 | ) | ||||||||
Net income per diluted common share | $ | 391,529 | 69,533 | $ | 5.63 | |||||||
Nine Months Ended September 29, 2018 | ||||||||||||
Net Income | Weighted- Average Shares | Per Share | ||||||||||
(Numerator) | (Denominator) | Amount | ||||||||||
Net income per basic common share | $ | 408,642 | 77,741 | $ | 5.26 | |||||||
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities | — | 654 | (0.05 | ) | ||||||||
Net income per diluted common share | $ | 408,642 | 78,395 | $ | 5.21 | |||||||
Currency Translation | Unrealized Gain (Loss) on Retirement Plans | Unrealized Gain (Loss) on Investments | Accumulated Other Comprehensive Income (Loss) | |||||||||||||
Balance at December 31, 2018 | $ | (105,697 | ) | $ | (9,869 | ) | $ | (2,405 | ) | $ | (117,971 | ) | ||||
Other comprehensive (loss) income, net of tax | (4,403 | ) | 449 | 2,344 | (1,610 | ) | ||||||||||
Balance at September 28, 2019 | $ | (110,100 | ) | $ | (9,420 | ) | $ | (61 | ) | $ | (119,581 | ) | ||||
Currency Translation | Unrealized | Accumulated Other Comprehensive Loss | ||||||||||
Balance at December 31, 2019 | $ | (104,066 | ) | $ | (15,405 | ) | $ | (119,471 | ) | |||
Other comprehensive loss, net of tax | (7,156 | ) | (49 | ) | (7,205 | ) | ||||||
Balance at September 26, 2020 | $ | (111,222 | ) | $ | (15,454 | ) | $ | (126,676 | ) | |||
Three Months Ended | ||||||||||||||||||||||||
September 28, 2019 | September 29, 2018 | |||||||||||||||||||||||
U.S. | U.S. | Non-U.S. | U.S. | U.S. | Non-U.S. | |||||||||||||||||||
Pension | Healthcare | Pension | Pension | Healthcare | Pension | |||||||||||||||||||
Plans | Plan | Plans | Plans | Plan | Plans | |||||||||||||||||||
Service cost | $ | — | $ | 124 | $ | 1,081 | $ | 142 | $ | 142 | $ | 1,311 | ||||||||||||
Interest cost | — | 194 | 426 | 1,622 | 159 | 406 | ||||||||||||||||||
Expected return on plan assets | — | (177 | ) | (535 | ) | (1,708 | ) | (177 | ) | (486 | ) | |||||||||||||
Net amortization: | ||||||||||||||||||||||||
Prior service credit | — | (5 | ) | (38 | ) | — | (4 | ) | (30 | ) | ||||||||||||||
Net actuarial loss | — | — | 132 | 771 | — | 167 | ||||||||||||||||||
Net periodic pension cost | $ | — | $ | 136 | $ | 1,066 | $ | 827 | $ | 120 | $ | 1,368 | ||||||||||||
Three Months Ended | ||||||||||||||||||||||||
September 26, 2020 | September 28, 2019 | |||||||||||||||||||||||
U.S. | U.S. Retiree | Non-U.S. | U.S. | U.S. Retiree | Non-U.S. | |||||||||||||||||||
Pension | Healthcare | Pension | Pension | Healthcare | Pension | |||||||||||||||||||
Plans | Plan | Plans | Plans | Plan | Plans | |||||||||||||||||||
Service cost | $ | — | $ | 197 | $ | 1,140 | $ | — | $ | 124 | $ | 1,081 | ||||||||||||
Interest cost | — | 180 | 353 | — | 194 | 426 | ||||||||||||||||||
Expected return on plan assets | — | (214 | ) | (476 | ) | — | (177 | ) | (535 | ) | ||||||||||||||
Net amortization: | ||||||||||||||||||||||||
Prior service credit | — | (4 | ) | (41 | ) | — | (5 | ) | (38 | ) | ||||||||||||||
Net actuarial loss | — | — | 397 | — | — | 132 | ||||||||||||||||||
Net periodic pension cost | $ | — | $ | 159 | $ | 1,373 | $ | — | $ | 136 | $ | 1,066 | ||||||||||||
Nine Months Ended | ||||||||||||||||||||||||
September 26, 2020 | September 28, 2019 | |||||||||||||||||||||||
U.S. | U.S. Retiree | Non-U.S. | U.S. | U.S. Retiree | Non-U.S. | |||||||||||||||||||
Pension | Healthcare | Pension | Pension | Healthcare | Pension | |||||||||||||||||||
Plans | Plan | Plans | Plans | Plan | Plans | |||||||||||||||||||
Service cost | $ | — | $ | 499 | $ | 3,334 | $ | — | $ | 374 | $ | 3,238 | ||||||||||||
Interest cost | — | 533 | 1,036 | 23 | 583 | 1,291 | ||||||||||||||||||
Expected return on plan assets | — | (653 | ) | (1,386 | ) | — | (531 | ) | (1,616 | ) | ||||||||||||||
Net amortization: | ||||||||||||||||||||||||
Prior service credit | — | (14 | ) | (122 | ) | — | (15 | ) | (113 | ) | ||||||||||||||
Net actuarial loss | — | — | 1,164 | — | — | 399 | ||||||||||||||||||
Net periodic pension cost | $ | — | $ | 365 | $ | 4,026 | $ | 23 | $ | 411 | $ | 3,199 | ||||||||||||
Nine Months Ended | ||||||||||||||||||||||||
September 28, 2019 | September 29, 2018 | |||||||||||||||||||||||
U.S. | U.S. | Non-U.S. | U.S. | U.S. | Non-U.S. | |||||||||||||||||||
Pension | Healthcare | Pension | Pension | Healthcare | Pension | |||||||||||||||||||
Plans | Plan | Plans | Plans | Plan | Plans | |||||||||||||||||||
Service cost | $ | — | $ | 374 | $ | 3,238 | $ | 426 | $ | 425 | $ | 4,024 | ||||||||||||
Interest cost | 23 | 583 | 1,291 | 4,868 | 477 | 1,250 | ||||||||||||||||||
Expected return on plan assets | — | (531 | ) | (1,616 | ) | (5,123 | ) | (530 | ) | (1,442 | ) | |||||||||||||
Net amortization: | ||||||||||||||||||||||||
Prior service credit | — | (15 | ) | (113 | ) | — | (14 | ) | (93 | ) | ||||||||||||||
Net actuarial loss | — | — | 399 | 2,312 | — | 515 | ||||||||||||||||||
Net periodic pension cost | $ | 23 | $ | 411 | $ | 3,199 | $ | 2,483 | $ | 358 | $ | 4,254 | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
Product net sales: | ||||||||||||||||
Waters instrument systems | $ | 223,859 | $ | 238,986 | $ | 647,248 | $ | 677,017 | ||||||||
Chemistry consumables | 100,256 | 95,979 | 299,801 | 293,818 | ||||||||||||
TA instrument systems | 46,458 | 43,557 | 131,292 | 135,673 | ||||||||||||
Total product sales | 370,573 | 378,522 | 1,078,341 | 1,106,508 | ||||||||||||
Service net sales: | ||||||||||||||||
Waters service | 188,031 | 180,830 | 556,128 | 543,411 | ||||||||||||
TA service | 18,674 | 18,669 | 55,833 | 54,991 | ||||||||||||
Total service sales | 206,705 | 199,499 | 611,961 | 598,402 | ||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | $ | 1,690,302 | $ | 1,704,910 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
Product net sales: | ||||||||||||||||
Waters instrument systems | $ | 225,790 | $ | 223,859 | $ | 550,018 | $ | 647,248 | ||||||||
Chemistry consumables | 108,175 | 100,256 | 300,525 | 299,801 | ||||||||||||
TA instrument systems | 42,274 | 46,458 | 114,799 | 131,292 | ||||||||||||
Total product sales | 376,239 | 370,573 | 965,342 | 1,078,341 | ||||||||||||
Service net sales: | ||||||||||||||||
Waters service | 199,501 | 188,031 | 562,843 | 556,128 | ||||||||||||
TA service | 18,044 | 18,674 | 50,522 | 55,833 | ||||||||||||
Total service sales | 217,545 | 206,705 | 613,365 | 611,961 | ||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | $ | 1,578,707 | $ | 1,690,302 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
Net Sales: | ||||||||||||||||
Asia: | ||||||||||||||||
China | $ | 111,657 | $ | 109,713 | $ | 314,544 | $ | 313,250 | ||||||||
Japan | 46,840 | 43,549 | 136,302 | 129,497 | ||||||||||||
Asia Other | 79,278 | 68,934 | 226,276 | 216,634 | ||||||||||||
Total Asia | 237,775 | 222,196 | 677,122 | 659,381 | ||||||||||||
Americas: | ||||||||||||||||
United States | 164,164 | 170,766 | 487,261 | 479,072 | ||||||||||||
Americas Other | 32,294 | 36,037 | 97,840 | 107,567 | ||||||||||||
Total Americas | 196,458 | 206,803 | 585,101 | 586,639 | ||||||||||||
Europe | 143,045 | 149,022 | 428,079 | 458,890 | ||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | $ | 1,690,302 | $ | 1,704,910 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
Net Sales: | ||||||||||||||||
Asia: | ||||||||||||||||
China | $ | 115,666 | $ | 111,657 | $ | 252,713 | $ | 314,544 | ||||||||
Japan | 44,779 | 46,840 | 131,098 | 136,302 | ||||||||||||
Asia Other | 75,737 | 79,278 | 219,660 | 226,276 | ||||||||||||
Total Asia | 236,182 | 237,775 | 603,471 | 677,122 | ||||||||||||
Americas: | ||||||||||||||||
United States | 172,267 | 164,164 | 465,093 | 487,261 | ||||||||||||
Americas Other | 27,180 | 32,294 | 81,312 | 97,840 | ||||||||||||
Total Americas | 199,447 | 196,458 | 546,405 | 585,101 | ||||||||||||
Europe | 158,155 | 143,045 | 428,831 | 428,079 | ||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | $ | 1,578,707 | $ | 1,690,302 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
Pharmaceutical | $ | 328,227 | $ | 325,166 | $ | 972,884 | $ | 968,848 | ||||||||
Industrial | 171,352 | 171,985 | 502,679 | 517,979 | ||||||||||||
Academic and governmental | 77,699 | 80,870 | 214,739 | 218,083 | ||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | $ | 1,690,302 | $ | 1,704,910 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
Pharmaceutical | $ | 343,001 | $ | 328,227 | $ | 926,582 | $ | 972,884 | ||||||||
Industrial | 179,128 | 171,352 | 474,592 | 502,679 | ||||||||||||
Academic and governmental | 71,655 | 77,699 | 177,533 | 214,739 | ||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | $ | 1,578,707 | $ | 1,690,302 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 28, 2019 | September 29, 2018 | September 28, 2019 | September 29, 2018 | |||||||||||||
Net sales recognized at a point in time: | ||||||||||||||||
Instrument systems | $ | 270,317 | $ | 282,543 | $ | 778,540 | $ | 812,690 | ||||||||
Chemistry consumables | 100,256 | 95,979 | 299,801 | 293,818 | ||||||||||||
Service sales recognized at a point in time (time & materials) | 75,240 | 75,769 | 232,806 | 228,685 | ||||||||||||
Total net sales recognized at a point in time | 445,813 | 454,291 | 1,311,147 | 1,335,193 | ||||||||||||
Net sales recognized over time: | ||||||||||||||||
Service and software maintenance sales recognized over time (contracts) | 131,465 | 123,730 | 379,155 | 369,717 | ||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | $ | 1,690,302 | $ | 1,704,910 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2020 | September 28, 2019 | September 26, 2020 | September 28, 2019 | |||||||||||||
Net sales recognized at a point in time: | ||||||||||||||||
Instrument systems | $ | 268,064 | $ | 270,317 | $ | 664,817 | $ | 778,540 | ||||||||
Chemistry consumables | 108,175 | 100,256 | 300,525 | 299,801 | ||||||||||||
Service sales recognized at a point in time (time & materials) | 92,145 | 75,240 | 238,754 | 232,806 | ||||||||||||
Total net sales recognized at a point in time | 468,384 | 445,813 | 1,204,096 | 1,311,147 | ||||||||||||
Net sales recognized over time: | ||||||||||||||||
Service and software maintenance sales recognized over time (contracts) | 125,400 | 131,465 | 374,611 | 379,155 | ||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | $ | 1,578,707 | $ | 1,690,302 | ||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 28, 2019 | September 29, 2018 | % change | September 28, 2019 | September 29, 2018 | % change | |||||||||||||||||||
Revenues: | ||||||||||||||||||||||||
Product sales | $ | 370,573 | $ | 378,522 | (2 | %) | $ | 1,078,341 | $ | 1,106,508 | (3 | %) | ||||||||||||
Service sales | 206,705 | 199,499 | 4 | % | 611,961 | 598,402 | 2 | % | ||||||||||||||||
Total net sales | 577,278 | 578,021 | — | 1,690,302 | 1,704,910 | (1 | %) | |||||||||||||||||
Costs and operating expenses: | ||||||||||||||||||||||||
Cost of sales | 241,055 | 241,139 | — | 711,632 | 705,695 | 1 | % | |||||||||||||||||
Selling and administrative expenses | 126,036 | 126,997 | (1 | %) | 393,583 | 394,049 | — | |||||||||||||||||
Research and development expenses | 34,333 | 35,173 | (2 | %) | 105,883 | 105,297 | 1 | % | ||||||||||||||||
Purchased intangibles amortization | 2,619 | 2,114 | 24 | % | 7,164 | 5,375 | 33 | % | ||||||||||||||||
Litigation provision (settlement) | — | 924 | (100 | %) | — | (748 | ) | 100 | % | |||||||||||||||
Operating income | 173,235 | 171,674 | 1 | % | 472,040 | 495,242 | (5 | %) | ||||||||||||||||
Operating income as a % of sales | 30.0 | % | 29.7 | % | 27.9 | % | 29.0 | % | ||||||||||||||||
Other expense | (496 | ) | (811 | ) | (39 | %) | (1,363 | ) | (2,293 | ) | (41 | %) | ||||||||||||
Interest expense, net | (8,001 | ) | (1,633 | ) | 390 | % | (16,826 | ) | (8,609 | ) | 95 | % | ||||||||||||
Income before income taxes | 164,738 | 169,230 | (3 | %) | 453,851 | 484,340 | (6 | %) | ||||||||||||||||
Provision for income taxes | 26,605 | 28,216 | (6 | %) | 62,322 | 75,698 | (18 | %) | ||||||||||||||||
Net income | $ | 138,133 | $ | 141,014 | (2 | %) | $ | 391,529 | $ | 408,642 | (4 | %) | ||||||||||||
Net income per diluted common share | $ | 2.07 | $ | 1.83 | 13 | % | $ | 5.63 | $ | 5.21 | 8 | % |
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 26, 2020 | September 28, 2019 | % change | September 26, 2020 | September 28, 2019 | % change | |||||||||||||||||||
Revenues: | ||||||||||||||||||||||||
Product sales | $ | 376,239 | $ | 370,573 | 2% | $ | 965,342 | $ | 1,078,341 | (10% | ) | |||||||||||||
Service sales | 217,545 | 206,705 | 5% | 613,365 | 611,961 | — | ||||||||||||||||||
Total net sales | 593,784 | 577,278 | 3% | 1,578,707 | 1,690,302 | (7% | ) | |||||||||||||||||
Costs and operating expenses: | ||||||||||||||||||||||||
Cost of sales | 262,342 | 241,055 | 9% | 686,120 | 711,632 | (4% | ) | |||||||||||||||||
Selling and administrative expenses | 135,430 | 126,036 | 7% | 400,614 | 393,583 | 2% | ||||||||||||||||||
Research and development expenses | 34,971 | 34,333 | 2% | 101,115 | 105,883 | (5% | ) | |||||||||||||||||
Purchased intangibles amortization | 2,657 | 2,619 | 1% | 7,900 | 7,164 | 10% | ||||||||||||||||||
Litigation provision | — | — | — | 1,180 | — | — | ||||||||||||||||||
Operating income | 158,384 | 173,235 | (9% | ) | 381,778 | 472,040 | (19% | ) | ||||||||||||||||
Operating income as a % of sales | 26.7% | 30.0% | 24.2% | 27.9% | ||||||||||||||||||||
Other expense | (1,039 | ) | (496 | ) | 109% | (2,149 | ) | (1,363 | ) | 58% | ||||||||||||||
Interest expense, net | (6,908 | ) | (8,001 | ) | (14% | ) | (25,966 | ) | (16,826 | ) | 54% | |||||||||||||
Income before income taxes | 150,437 | 164,738 | (9% | ) | 353,663 | 453,851 | (22% | ) | ||||||||||||||||
Provision for income taxes | 23,668 | 26,605 | (11% | ) | 50,403 | 62,322 | (19% | ) | ||||||||||||||||
Net income | $ | 126,769 | $ | 138,133 | (8% | ) | $ | 303,260 | $ | 391,529 | (23% | ) | ||||||||||||
Net income per diluted common share | $ | 2.03 | $ | 2.07 | (2% | ) | $ | 4.86 | $ | 5.63 | (14% | ) |
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 28, 2019 | September 29, 2018 | % change | September 28, 2019 | September 29, 2018 | % change | |||||||||||||||||||
Net Sales: | ||||||||||||||||||||||||
Asia: | ||||||||||||||||||||||||
China | $ | 111,657 | $ | 109,713 | 2 | % | $ | 314,544 | $ | 313,250 | — | |||||||||||||
Japan | 46,840 | 43,549 | 8 | % | 136,302 | 129,497 | 5 | % | ||||||||||||||||
Asia Other | 79,278 | 68,934 | 15 | % | 226,276 | 216,634 | 4 | % | ||||||||||||||||
Total Asia | 237,775 | 222,196 | 7 | % | 677,122 | 659,381 | 3 | % | ||||||||||||||||
Americas: | ||||||||||||||||||||||||
United States | 164,164 | 170,766 | (4 | %) | 487,261 | 479,072 | 2 | % | ||||||||||||||||
Americas Other | 32,294 | 36,037 | (10 | %) | 97,840 | 107,567 | (9 | %) | ||||||||||||||||
Total Americas | 196,458 | 206,803 | (5 | %) | 585,101 | 586,639 | — | |||||||||||||||||
Europe | 143,045 | 149,022 | (4 | %) | 428,079 | 458,890 | (7 | %) | ||||||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | — | $ | 1,690,302 | $ | 1,704,910 | (1 | %) | |||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 26, 2020 | September 28, 2019 | % change | September 26, 2020 | September 28, 2019 | % change | |||||||||||||||||||
Net Sales: | ||||||||||||||||||||||||
Asia: | ||||||||||||||||||||||||
China | $ | 115,666 | $ | 111,657 | 4% | $ | 252,713 | $ | 314,544 | (20% | ) | |||||||||||||
Japan | 44,779 | 46,840 | (4% | ) | 131,098 | 136,302 | (4% | ) | ||||||||||||||||
Asia Other | 75,737 | 79,278 | (4% | ) | 219,660 | 226,276 | (3% | ) | ||||||||||||||||
Total Asia | 236,182 | 237,775 | (1% | ) | 603,471 | 677,122 | (11% | ) | ||||||||||||||||
Americas: | ||||||||||||||||||||||||
United States | 172,267 | 164,164 | 5% | 465,093 | 487,261 | (5% | ) | |||||||||||||||||
Americas Other | 27,180 | 32,294 | (16% | ) | 81,312 | 97,840 | (17% | ) | ||||||||||||||||
Total Americas | 199,447 | 196,458 | 2% | 546,405 | 585,101 | (7% | ) | |||||||||||||||||
Europe | 158,155 | 143,045 | 11% | 428,831 | 428,079 | — | ||||||||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | 3% | $ | 1,578,707 | $ | 1,690,302 | (7% | ) | |||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 28, 2019 | September 29, 2018 | % change | September 28, 2019 | September 29, 2018 | % change | |||||||||||||||||||
Pharmaceutical | $ | 328,227 | $ | 325,166 | 1 | % | $ | 972,884 | $ | 968,848 | — | |||||||||||||
Industrial | 171,352 | 171,985 | — | 502,679 | 517,979 | (3 | %) | |||||||||||||||||
Academic and governmental | 77,699 | 80,870 | (4 | %) | 214,739 | 218,083 | (2 | %) | ||||||||||||||||
Total net sales | $ | 577,278 | $ | 578,021 | 0 | % | $ | 1,690,302 | $ | 1,704,910 | (1 | %) | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 26, 2020 | September 28, 2019 | % change | September 26, 2020 | September 28, 2019 | % change | |||||||||||||||||||
Pharmaceutical | $ | 343,001 | $ | 328,227 | 5% | $ | 926,582 | $ | 972,884 | (5%) | ||||||||||||||
Industrial | 179,128 | 171,352 | 5% | 474,592 | 502,679 | (6%) | ||||||||||||||||||
Academic and governmental | 71,655 | 77,699 | (8%) | 177,533 | 214,739 | (17%) | ||||||||||||||||||
Total net sales | $ | 593,784 | $ | 577,278 | 3% | $ | 1,578,707 | $ | 1,690,302 | (7%) | ||||||||||||||
Three Months Ended | ||||||||||||||||||||
September 28, 2019 | % of Total | September 29, 2018 | % of Total | % change | ||||||||||||||||
Waters instrument systems | $ | 223,859 | 44 | % | $ | 238,986 | 46 | % | (6 | %) | ||||||||||
Chemistry consumables | 100,256 | 19 | % | 95,979 | 19 | % | 4 | % | ||||||||||||
Total Waters product sales | 324,115 | 63 | % | 334,965 | 65 | % | (3 | %) | ||||||||||||
Waters service | 188,031 | 37 | % | 180,830 | 35 | % | 4 | % | ||||||||||||
Total Waters net sales | $ | 512,146 | 100 | % | $ | 515,795 | 100 | % | (1 | %) | ||||||||||
Nine Months Ended | ||||||||||||||||||||
September 28, 2019 | % of Total | September 29, 2018 | % of Total | % change | ||||||||||||||||
Waters instrument systems | $ | 647,248 | 43 | % | $ | 677,017 | 45 | % | (4 | %) | ||||||||||
Chemistry consumables | 299,801 | 20 | % | 293,818 | 19 | % | 2 | % | ||||||||||||
Total Waters product sales | 947,049 | 63 | % | 970,835 | 64 | % | (2 | %) | ||||||||||||
Waters service | 556,128 | 37 | % | 543,411 | 36 | % | 2 | % | ||||||||||||
Total Waters net sales | $ | 1,503,177 | 100 | % | $ | 1,514,246 | 100 | % | (1 | %) | ||||||||||
Three Months Ended | ||||||||||||||||||||
September 26, 2020 | % of Total | September 28, 2019 | % of Total | % change | ||||||||||||||||
Waters instrument systems | $ | 225,790 | 42% | $ | 223,859 | 44% | 1% | |||||||||||||
Chemistry consumables | 108,175 | 21% | 100,256 | 19% | 8% | |||||||||||||||
Total Waters product sales | 333,965 | 63% | 324,115 | 63% | 3% | |||||||||||||||
Waters service | 199,501 | 37% | 188,031 | 37% | 6% | |||||||||||||||
Total Waters net sales | $ | 533,466 | 100% | $ | 512,146 | 100% | 4% | |||||||||||||
Nine Months Ended | ||||||||||||||||||||
September 26, 2020 | % of Total | September 28, 2019 | % of Total | % change | ||||||||||||||||
Waters instrument systems | $ | 550,018 | 39% | $ | 647,248 | 43% | (15%) | |||||||||||||
Chemistry consumables | 300,525 | 21% | 299,801 | 20% | — | |||||||||||||||
Total Waters product sales | 850,543 | 60% | 947,049 | 63% | (10%) | |||||||||||||||
Waters service | 562,843 | 40% | 556,128 | 37% | 1% | |||||||||||||||
Total Waters net sales | $ | 1,413,386 | 100% | $ | 1,503,177 | 100% | (6%) | |||||||||||||
Three Months Ended | ||||||||||||||||||||
September 28, 2019 | % of Total | September 29, 2018 | % of Total | % change | ||||||||||||||||
TA instrument systems | $ | 46,458 | 71 | % | $ | 43,557 | 70 | % | 7 | % | ||||||||||
TA service | 18,674 | 29 | % | 18,669 | 30 | % | — | |||||||||||||
Total TA net sales | $ | 65,132 | 100 | % | $ | 62,226 | 100 | % | 5 | % | ||||||||||
Nine Months Ended | ||||||||||||||||||||
September 28, 2019 | % of Total | September 29, 2018 | % of Total | % change | ||||||||||||||||
TA instrument systems | $ | 131,292 | 70 | % | $ | 135,673 | 71 | % | (3 | %) | ||||||||||
TA service | 55,833 | 30 | % | 54,991 | 29 | % | 2 | % | ||||||||||||
Total TA net sales | $ | 187,125 | 100 | % | $ | 190,664 | 100 | % | (2 | %) | ||||||||||
Three Months Ended | ||||||||||||||||||||
September 26, 2020 | % of Total | September 28, 2019 | % of Total | % change | ||||||||||||||||
TA instrument systems | $ | 42,274 | 70% | $ | 46,458 | 71% | (9% | ) | ||||||||||||
TA service | 18,044 | 30% | 18,674 | 29% | (3% | ) | ||||||||||||||
Total TA net sales | $ | 60,318 | 100% | $ | 65,132 | 100% | (7% | ) | ||||||||||||
Nine Months Ended | ||||||||||||||||||||
September 26, 2020 | % of Total | September 28, 2019 | % of Total | % change | ||||||||||||||||
TA instrument systems | $ | 114,799 | 69% | $ | 131,292 | 70% | (13% | ) | ||||||||||||
TA service | 50,522 | 31% | 55,833 | 30% | (10% | ) | ||||||||||||||
Total TA net sales | $ | 165,321 | 100% | $ | 187,125 | 100% | (12% | ) | ||||||||||||
Nine Months Ended | ||||||||
September 28, 2019 | September 29, 2018 | |||||||
Net income | $ | 391,529 | $ | 408,642 | ||||
Depreciation and amortization | 80,319 | 82,811 | ||||||
Stock-based compensation | 28,917 | 28,184 | ||||||
Deferred income taxes | 1,817 | 278 | ||||||
Change in accounts receivable | 57,897 | 36,893 | ||||||
Change in inventories | (83,973 | ) | (47,826 | ) | ||||
Change in accounts payable and other current liabilities | (493 | ) | (93,637 | ) | ||||
Change in deferred revenue and customer advances | 34,926 | 23,085 | ||||||
Effect of the 2017 Tax Cuts & Jobs Act | (3,229 | ) | 12,450 | |||||
Other changes | (56,518 | ) | (27,983 | ) | ||||
Net cash provided by operating activities | 451,192 | 422,897 | ||||||
Net cash provided by investing activities | 825,441 | 1,257,718 | ||||||
Net cash used in financing activities | (1,661,541 | ) | (1,626,443 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (6,723 | ) | (7,118 | ) | ||||
(Decrease) increase in cash and cash equivalents | $ | (391,631 | ) | $ | 47,054 | |||
Nine Months Ended | ||||||||
September 26, 2020 | September 28, 2019 | |||||||
Net income | $ | 303,260 | $ | 391,529 | ||||
Depreciation and amortization | 91,091 | 80,319 | ||||||
Stock-based compensation | 27,715 | 28,917 | ||||||
Deferred income taxes | 1,089 | 1,817 | ||||||
Change in accounts receivable | 96,955 | 57,897 | ||||||
Change in inventories | (8,139 | ) | (83,973 | ) | ||||
Change in accounts payable and other current liabilities | 46,721 | (493 | ) | |||||
Change in deferred revenue and customer advances | 32,053 | 34,926 | ||||||
Effect of the 2017 Tax Cuts & Jobs Act | — | (3,229 | ) | |||||
Other changes | (67,720 | ) | (56,518 | ) | ||||
Net cash provided by operating activities | 523,025 | 451,192 | ||||||
Net cash (used in) provided by investing activities | (226,561 | ) | 825,441 | |||||
Net cash used in financing activities | (267,968 | ) | (1,661,541 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | 10,723 | (6,723 | ) | |||||
Increase (decrease) in cash and cash equivalents | $ | 39,219 | $ | (391,631 | ) | |||
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs (2) | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Programs (2) | ||||||||||||
June 30, 2019 to July 27, 2019 | 959 | $ | 216.81 | 959 | $ | 2,633,353 | ||||||||||
July 28, 2019 to August 24, 2019 | 830 | $ | 209.60 | 830 | $ | 2,459,393 | ||||||||||
August 25, 2019 to September 28, 2019 | 937 | $ | 220.19 | 937 | $ | 2,253,122 | ||||||||||
Total | 2,726 | $ | 215.78 | 2,726 | $ | 2,253,122 | ||||||||||
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Programs (2) | ||||||||||||
June 28, 2020 to July 25, 2020 | — | $ | — | — | $ | 1,524,905 | ||||||||||
July 26, 2020 to August 22, 2020 | — | $ | — | — | $ | 1,524,905 | ||||||||||
August 23, 2020 to September 26, 2020 | — | $ | — | — | $ | 1,524,905 | ||||||||||
Total | — | $ | — | — | $ | 1,524,905 | ||||||||||
(1) | The |
(2) | In January 2019, the Company’s Board of Directors authorized the Company to repurchase up to $4 billion of its outstanding common stock in open market or private transactions over a two-year period. This new program replaced the remaining amounts available under thepre-existing authorization. During the second quarter of 2020, the Company has temporarily suspended its share repurchases due to the uncertain business conditions caused by theCOVID-19 pandemic. |
Exhibit Number | Description of Document | |||
10.1 | ||||
10.2 | Change of Control/Severance Agreement, dated July 14, 2020 between Waters Corporation and Udit Batra (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 27, 2020 (File No. 001-14010)). | |||
31.1 | ||||
31.2 | ||||
32.1 | ||||
32.2 | ||||
101 | ||||
The following materials from Waters Corporation’s Quarterly Report on Form 10-Q for the quarter ended September | ||||
104 | ||||
Cover Page Interactive Date File (formatted in iXBRL and contained in Exhibit 101). |
(*) | This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any filing, except to the extent the Company specifically incorporates it by reference. |
/s/ Sherry L. Buck |
Sherry L. Buck |
Senior Vice President and |
Chief Financial Officer |